Dennis A Hesselink

13PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Sensor technology (incl. chemical aspects)Epidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 07, 2025
Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial.

Jan-Stephan F Sanders, Silke E de Boer, Jip Jonker

|Sep 02, 2025
A Comprehensive Assessment of Plasma CXCL9 and CXCL10 in Improving Clinical Prediction Models for Kidney Allograft Rejection.

Alvaro Assis de Souza, Dennis A Hesselink, Carolien C H M Maas

|Jun 29, 2025
Development of a ribavirin dosing regimen in transplant recipients with chronic hepatitis E virus infection: a population pharmacokinetic and -dynamic model.

Midas B Mulder, Martijn van Noort, Robert A de Man

|May 15, 2025
Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic-Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation.

Lukas K van Vugt, Tom C Zwart, Suzanne Bezstarosti

|Mar 19, 2025
The tacrolimus concentration-to-dose ratio is associated with kidney function in heart transplant recipients.

Maaike R Schagen, Teun B Petersen, Boris C A Seijkens

|Dec 05, 2024
Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant Rejection.

Lukas K van Vugt, Erzsi Tegzess, Marieke van der Zwan

Pageof 3

Frequent Collaborators

7 joint publications

Brenda Cm de Winter

2 joint publications

Marian Clahsen-van Groningen

2 joint publications

Jan-Stephan F Sanders

2 joint publications

Teun van Gelder